Cargando…
Musculoskeletal adverse reactions after immunotherapy for cancer: A case series
Immunotherapy has revolutionized cancer treatment. Immune checkpoint inhibitors (ICIs) including antibodies targeting cytotoxic T lymphocyte associated antigen-4 and programmed cell death 1 have been shown to be effective in the treatment of certain types of cancer. The benefit of these therapies is...
Autores principales: | Creţu, Ioana, Bojincă, Mihai, Milicescu, Mihaela, Cursaru, Adrian, Șerban, Bogdan, Crețu, Bogdan, Iordache, Sergiu, Pop, Corina Silvia, Cîrstoiu, Cătălin, Ionescu, Ruxandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343871/ https://www.ncbi.nlm.nih.gov/pubmed/34373713 http://dx.doi.org/10.3892/etm.2021.10459 |
Ejemplares similares
-
Rheumatological Adverse Events Following Immunotherapy for Cancer
por: Cretu, Ioana, et al.
Publicado: (2022) -
Management of Acetabular Bone Loss in Hip Revision Arthroplasty: Case Series Presentation
por: Cursaru, Adrian, et al.
Publicado: (2023) -
Cerebral Tuberculosis in a Patient Following Treatment With Infliximab for Ankylosing Spondylitis: A Case Report
por: Cretu, Ioana, et al.
Publicado: (2023) -
Melorheostosis: A Review of the Literature and a Case Report
por: Iordache, Sergiu, et al.
Publicado: (2023) -
Metagenomic Next-Generation Sequencing for Periprosthetic Joint Infections
por: Cretu, Bogdan, et al.
Publicado: (2023)